Literature DB >> 6151178

Calcium/phospholipid-dependent protein kinase (protein kinase C) phosphorylates and activates tyrosine hydroxylase.

K A Albert, E Helmer-Matyjek, A C Nairn, T H Müller, J W Haycock, L A Greene, M Goldstein, P Greengard.   

Abstract

Protein kinase C, purified to homogeneity, was found to phosphorylate and activate tyrosine hydroxylase that had been partially purified from pheochromocytoma PC 12 cells. These actions of protein kinase C required the presence of calcium and phospholipid. This phosphorylation of tyrosine hydroxylase reduced the Km for the cofactor 6-methyltetrahydropterine from 0.45 mM to 0.11 mM, increased the Ki for dopamine from 4.2 microM to 47.5 microM, and produced no change in the Km for tyrosine. Little or no change in apparent Vmax was observed. These kinetic changes are similar to those seen upon activation of tyrosine hydroxylase by cAMP-dependent protein kinase. Two-dimensional phosphopeptide maps of tyrosine hydroxylase were identical whether the phosphorylation was catalyzed by protein kinase C or by the catalytic subunit of cAMP-dependent protein kinase. Both protein kinases phosphorylated serine residues. The results suggest that protein kinase C and cAMP-dependent protein kinase phosphorylate the same site(s) on tyrosine hydroxylase and activate tyrosine hydroxylase by the same mechanism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6151178      PMCID: PMC392222          DOI: 10.1073/pnas.81.24.7713

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  A RAPID AND SIMPLE RADIOASSAY FOR TYROSINE HYDROXYLASE ACTIVITY.

Authors:  T NAGATSU; M LEVITT; S UDENFRIEND
Journal:  Anal Biochem       Date:  1964-09       Impact factor: 3.365

2.  Dopaminergic neurons: effects of electrical stimulation on dopamine biosynthesis.

Authors:  L C Murrin; R H Roth
Journal:  Mol Pharmacol       Date:  1976-05       Impact factor: 4.436

3.  Stimulation of tyrosine hydroxylase activity by cyclic AMP in synaptosomes and in soluble striatal enzyme preparations.

Authors:  M Goldstein; R L Bronaugh; B Ebstein; C Roberge
Journal:  Brain Res       Date:  1976-06-18       Impact factor: 3.252

4.  Tyrosine hydroxylase. Activation by protein phosphorylation and end product inhibition.

Authors:  M M Ames; P Lerner; W Lovenberg
Journal:  J Biol Chem       Date:  1978-01-10       Impact factor: 5.157

Review 5.  Regulation of norepinephrine biosynthesis.

Authors:  N Weiner
Journal:  Annu Rev Pharmacol       Date:  1970       Impact factor: 13.820

6.  Pheochromocytoma.

Authors:  S Warren; R N Chute
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

7.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

8.  Evidence for involvement of protein kinase in the activation by adenosine 3':5'-monophosphate of brain tyrosine 3-monooxygenase.

Authors:  V H Morgenroth; L R Hegstrand; R H Roth; P Greengard
Journal:  J Biol Chem       Date:  1975-03-10       Impact factor: 5.157

9.  Adenosine 3':5'-monophosphate-regulated phosphoprotein system of neuronal membranes. I. Solubilization, purification, and some properties of an endogenous phosphoprotein.

Authors:  T Ueda; P Greengard
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

10.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

Authors:  L A Greene; A S Tischler
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

View more
  36 in total

1.  Acute and specific modulation of presynaptic aromatization in the vertebrate brain.

Authors:  Charlotte A Cornil; Cary H Leung; Eric R Pletcher; Kevin C Naranjo; Sara J Blauman; Colin J Saldanha
Journal:  Endocrinology       Date:  2012-04-16       Impact factor: 4.736

2.  Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat.

Authors:  Katy M Webb; Michael Y Aksenov; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

3.  Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease.

Authors:  J Garcia de Yebenes; J Yebenes; M A Mena
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 4.  The role of protein kinase C and its neuronal substrates dephosphin, B-50, and MARCKS in neurotransmitter release.

Authors:  P J Robinson
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

5.  Direct binding of GTP cyclohydrolase and tyrosine hydroxylase: regulatory interactions between key enzymes in dopamine biosynthesis.

Authors:  Kevin M Bowling; Zhinong Huang; Dong Xu; Faiza Ferdousy; Christopher D Funderburk; Nirmala Karnik; Wendi Neckameyer; Janis M O'Donnell
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

Review 6.  Calcium/calmodulin-dependent protein kinase II.

Authors:  R J Colbran; C M Schworer; Y Hashimoto; Y L Fong; D P Rich; M K Smith; T R Soderling
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

Review 7.  The role of phosphoinositides in signal transduction.

Authors:  M C Sekar; L E Hokin
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

8.  Veratridine-induced phosphorylation and activation of tyrosine hydroxylase, and synthesis of catecholamines in cultured bovine adrenal medullary cells.

Authors:  Y Uezono; N Yanagihara; A Wada; Y Koda; K Yokota; H Kobayashi; F Izumi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

9.  The phosphorylation of choline acetyltransferase.

Authors:  G Bruce; L B Hersh
Journal:  Neurochem Res       Date:  1989-07       Impact factor: 3.996

10.  The role of de novo catecholamine synthesis in mediating methylmercury-induced vesicular dopamine release from rat pheochromocytoma (PC12) cells.

Authors:  Chelsea T Tiernan; Ethan A Edwin; John L Goudreau; William D Atchison; Keith J Lookingland
Journal:  Toxicol Sci       Date:  2013-02-19       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.